School of Pharmacy - News

Researchers at the UEF have identified a transporter protein with the potential to open new avenues for improving creatine delivery into the brain and for developing other therapies targeting the central nervous system.

The interview study explored pharmaceutical sector stakeholders’ views on how changes to EU chemicals legislation affect the green transformation in the sector.

An international research team has developed microscopic particles that can make blind retinas respond to light. The preclinical testing was carried out at the University of Eastern Finland.

“I’m afraid few patients and healthcare professionals know how many new prescription drugs enter the market with limited evidence on their benefit and safety,” says Dr Anita Wagner.

The use of oral anticoagulants among persons with Alzheimer's disease increased before diagnosis but declined after diagnosis, which may reflect concerns about safety issues as the disease progresses.

Researchers found that retinal dopamine concentrations increase in the tissue even before structural degeneration begins and remain elevated as the disease progresses.

The PhD study focused on the development of long-acting ocular drug delivery systems.

Different BMI trajectories were associated with significant differences in comorbidities, diabetes medication and healthcare service use over the ten-year follow-up period.

The new study provides Finnish norm values for both everyday functioning and work ability, as well as for a newly developed measure, productivity-adjusted life expectancy.

A new study reports the discovery and application of a novel therapeutic strategy to selectively target EGFR and other kinases with controlled release in tumour microenvironments.